Company: MBIO
Filing Date: 2025-04-01
Form Type: 424B3
Source: 0001104659-25-030657
Chunk: 183

Company: MUSTANG BIO, INC.
Filing Date: 2025-04-01
Form: 424B3
Chunk 183
---
 |     493 | ​ |   |  -2,342 | ​ |
| Net Loss                                                                                   | ​ | $                               | -15,752 | ​ | $ | -51,602 | ​ |
| ​                                                                                          | ​ |                                 |       ​ | ​ |   |         | ​ |
| Net loss per Class A common and common shares outstanding, basic and diluted               | ​ | $                               |  -38.57 | ​ | $ | -299.95 | ​ |
| ​                                                                                          | ​ |                                 |         | ​ |   |         | ​ |
| Weighted average number of Class A common and common shares outstanding, basic and diluted | ​ |                                 | 609,696 | ​ |   | 172,031 | ​ |

<div align='center'>See accompanying notes to financial statements.

F-5</div>

Table of Contents

<div align='center'>MUSTANG BIO, INC.

STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands, except share amounts)</div>

| ​                                                                          
 ​                                                                          
 ​                                                                          
 ​                                                                          | ​ 
 ​ 
 ​ |                       ​ 
                       ​ 
 Class A Preferred Stock 
                  Shares | ​ 
 ​ | ​      
 ​      
 Amount | ​ 
 ​ | ​ 
 ​ 
 ​ |                     ​ 
                     ​ 
 Class A Common Shares 
                Shares | ​ 
 ​ | ​      
 ​      
 Amount | ​ 
 ​ | ​ 
 ​ 
 ​ |             ​ 
             ​ 
 Common Shares 
        Shares | ​ 
 ​ | ​      
 ​      
 Amount |   ​ 
   ​ | ​ 
 ​ 
 ​ | ​        
 Common   
 Stock    
 Issuable |      ​ | ​ 
 ​ 
 ​ | ​          
 Additional 
 Paid-in    
 Capital    |       ​ | ​ 
 ​ 
 ​ | ​           
 ​           
 Accumulated 
 Deficit     |        ​ 
        ​ | ​ 
 ​ 
 ​ | ​             
 Total         
 Stockholders’ 
 Equity        |       ​ |
|:---------------------------------------------------------------------------|:--|------------------------:|:--|:-------|:--|:--|----------------------:|:--|:-------|:--|:--|--------------:|:--|:-------|----:|:--|:---------|-------:|:--|:-----------|--------:|:--|:------------|---------:|:--|:--------------|--------:|
| Balances at December 31, 2022                                              |